Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...

OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial ...

Researchers are engineering bacteria to invade tumors and consume them from the inside. Because tumor cores lack oxygen, they ...

ISC Class 12 Competency Focused Questions 2026, released by the CISCE Board, are essential for board exam preparation. With exams scheduled from February 12 to April 6, 2026, students should practise ...

Ghana, with a population of about 35 million people, does not have a single standalone comprehensive cancer centre of excellence, health experts have warned. Speaking at the World Cancer Day ...

Researchers found that both how often and how much someone drinks significantly shape their cancer risk, even at moderate levels. Vulnerability varies across groups, with genetics, socioeconomic ...

Leading regional cancer doctors have welcomed a new ten year plan designed to transform care and committed to "continuing our efforts" to boost screening and ensure illness is diagnosed as quickly as ...

Study finds Fusobacterium nucleatum can drive DNA damage, tumor growth and metastasis, with heightened effects in cells with BRCA1 gene mutations. Researchers at the Johns Hopkins Kimmel Cancer Center ...

ImmunityBio, Inc. (NYSE: IBRX), a commercial stage immunotherapy company developing next generation therapies that drive immunological memory and restore immune competence, today announced that the ...

Americans are living in parallel AI universes. For much of the country, AI has come to mean ChatGPT, Google’s AI overviews, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Gemini Bioproducts LLC in West ...

Opening Bid Unfiltered is available on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. If you aren’t paying attention to the companies behind a new wave of AI-driven drug ...